‌

US Patent 9422564 Immunostimulatory sequence oligonucleotides and methods of using the same

Patent 9422564 was granted and assigned to Dynavax Technologies on August, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Dynavax Technologies

Current Assignee

Dynavax Technologies

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

94225640

Patent Inventor Names

Dino Dina0

Jason Marshall0

Karen L. Fearon0

Date of Patent

August 23, 2016

Patent Application Number

145189330

Date Filed

October 20, 2014

Patent Citations Received

‌

US Patent 11918648 Combination of a PD-1 antagonist and CpG-C type oligonucleotide for treating cancer

Patent Primary Examiner

‌

Nita M. Minnifield

Patent abstract

The invention provides immunomodulatory polynucleotides and methods for immunomodulation of individuals using the immunomodulatory polynucleotides.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9422564 Immunostimulatory sequence oligonucleotides and methods of using the same

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API